Coloplast A/S (CLPBY)
6.45
-0.06
(-0.92%)
USD |
OTCM |
Sep 18, 16:00
Coloplast Enterprise Value : 16.89B for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 16.89B |
| September 17, 2026 | 17.02B |
| September 16, 2026 | 16.89B |
| September 15, 2026 | 17.04B |
| September 14, 2026 | 17.10B |
| September 11, 2026 | 17.14B |
| September 10, 2026 | 17.51B |
| September 09, 2026 | 17.49B |
| September 08, 2026 | 17.97B |
| September 04, 2026 | 18.22B |
| September 03, 2026 | 18.61B |
| September 02, 2026 | 18.86B |
| September 01, 2026 | 18.63B |
| August 31, 2026 | 18.32B |
| August 28, 2026 | 18.38B |
| August 27, 2026 | 18.36B |
| August 26, 2026 | 18.32B |
| August 25, 2026 | 18.57B |
| August 24, 2026 | 18.53B |
| August 21, 2026 | 17.78B |
| August 20, 2026 | 17.62B |
| August 19, 2026 | 17.99B |
| August 18, 2026 | 17.60B |
| August 17, 2026 | 17.16B |
| August 14, 2026 | 17.37B |
| Date | Value |
|---|---|
| August 13, 2026 | 17.43B |
| August 12, 2026 | 17.37B |
| August 11, 2026 | 17.71B |
| August 10, 2026 | 17.31B |
| August 07, 2026 | 17.62B |
| August 06, 2026 | 17.22B |
| August 05, 2026 | 17.41B |
| August 04, 2026 | 17.45B |
| August 03, 2026 | 17.62B |
| July 31, 2026 | 17.41B |
| July 30, 2026 | 17.53B |
| July 29, 2026 | 17.37B |
| July 28, 2026 | 17.31B |
| July 27, 2026 | 16.93B |
| July 24, 2026 | 16.35B |
| July 23, 2026 | 16.04B |
| July 22, 2026 | 16.46B |
| July 21, 2026 | 16.64B |
| July 20, 2026 | 16.85B |
| July 17, 2026 | 16.89B |
| July 16, 2026 | 16.75B |
| July 15, 2026 | 16.54B |
| July 14, 2026 | 16.14B |
| July 13, 2026 | 16.37B |
| July 10, 2026 | 16.21B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ambu A/S | 2.646B |
| Abbott Laboratories | 205.21B |
| AngioDynamics, Inc. | 600.95M |
| Alphatec Holdings, Inc. | 2.063B |
| AtriCure, Inc. | 2.862B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 227.46M |
| Revenue (Quarterly) | 1.144B |
| Total Expenses (Quarterly) | 916.84M |
| EPS Diluted (Quarterly) | 0.1009 |
| Gross Profit Margin (Quarterly) | 66.73% |
| Profit Margin (Quarterly) | 19.88% |
| Earnings Yield | 2.96% |
| Operating Earnings Yield | 8.02% |
| Normalized Earnings Yield | 5.343 |